Gene · 3385
Papers1,776
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,776
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intercellular Adhesion Molecule 1: More than a Leukocyte Adhesion Molecule. | Biology (Basel) | 2023 | 37237555 | PubTator, text mining | PubMed |
| Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis. | Cell Death Discov | 2023 | 37221171 | PubTator, text mining | PubMed |
| The genetic landscape and possible therapeutics of neurofibromatosis type 2. | Cancer Cell Int | 2023 | 37217995 | PubTator, text mining | PubMed |
| LFA-1 Activation in T-Cell Migration and Immunological Synapse Formation. | Cells | 2023 | 37190045 | PubTator, text mining | PubMed |
| A quantitative planar array screen of 440 proteins uncovers novel serum protein biomarkers of idiopathic nephrotic syndrome. | MedComm (2020) | 2023 | 37180824 | PubTator, text mining | PubMed |
| Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints. | Cells | 2023 | 37174696 | PubTator, text mining | PubMed |
| Single-cell profiling of peripheral blood and muscle cells reveals inflammatory features of juvenile dermatomyositis. | Front Cell Dev Biol | 2023 | 37152289 | PubTator, text mining | PubMed |
| Identification of NETs-related biomarkers and molecular clusters in systemic lupus erythematosus. | Front Immunol | 2023 | 37143669 | PubTator, text mining | PubMed |
| Immunohistochemical Analysis of Adhesion Molecules E-Selectin, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Inflammatory Lesions of Atopic Dermatitis. | Life (Basel) | 2023 | 37109462 | PubTator, text mining | PubMed |
| Virus-host Interactions in Early Japanese Encephalitis Virus Infection. | Virus Res | 2023 | 37086856 | PubTator, text mining | PubMed |
| Potential treatments of COVID-19: Drug repurposing and therapeutic interventions. | J Pharmacol Sci | 2023 | 37059487 | PubTator, text mining | PubMed |
| A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases. | Front Immunol | 2023 | 37051237 | PubTator, text mining | PubMed |
| Longitudinal home self-collection of capillary blood using homeRNA correlates interferon and innate viral defense pathways with SARS-CoV-2 viral clearance. | medRxiv | 2023 | 37034678 | PubTator, text mining | PubMed |
| Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy. | Eur J Med Res | 2023 | 37013663 | PubTator, text mining | PubMed |
| DC-SIGN receptor is expressed by cells from cutaneous leishmaniasis lesions and differentially binds to Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis promastigotes. | Mem Inst Oswaldo Cruz | 2023 | 36995847 | PubTator, text mining | PubMed |
| Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells. | Biomolecules | 2023 | 36979408 | PubTator, text mining | PubMed |
| Step-Growth Glycopolymers with a Defined Tacticity for Selective Carbohydrate-Lectin Recognition. | Biomacromolecules | 2023 | 36976928 | PubTator, text mining | PubMed |
| Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells. | Front Cell Dev Biol | 2023 | 36968199 | PubTator, text mining | PubMed |
| Ezrin expression in female reproductive tissues: A review of regulation and pathophysiological implications. | Front Cell Dev Biol | 2023 | 36968198 | PubTator, text mining | PubMed |
| Development and evaluation of a mouse model susceptible to severe fever with thrombocytopenia syndrome virus by rAAV-based exogenous human DC-SIGN expression. | Microb Pathog | 2023 | 36966885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3385/papers?page=6